RUNX1 and acute myeloid leukemia: Some cytogenetic alterations already have a well-established immunophenotype in the literature, such as AML patients with PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11, as shown in Table 2, where red and green are consistent with the increase and decrease in the markers’ expression, respectively.